New heart surgery treatment aims to curb dangerous bleeding
Disease control
Recruiting now
This study is testing if a concentrated clotting factor treatment (PCC) works as well as standard plasma (FFP) to control bleeding in patients having heart surgery. About 820 patients will be randomly assigned to receive one of the two treatments during their operation. The main …
Phase: PHASE4 • Sponsor: SHI Jia • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC